Catabasis pharmaceuticals inc (CATB)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Sep'14Jun'14
Revenue

-

-

-

-

-

-

-

-

-

-

250

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Research and development

5,289

4,263

4,697

5,160

4,197

3,659

3,897

4,239

5,247

3,989

4,776

4,519

5,398

6,260

5,936

6,818

6,436

6,670

5,813

5,931

4,616

4,543

3,722

General and administrative

2,753

2,484

1,985

2,165

2,137

2,429

2,111

2,397

2,392

1,723

2,426

2,400

2,363

2,413

2,347

2,578

2,770

2,664

2,388

1,833

1,744

1,427

1,642

Total operating expenses

8,042

6,747

6,682

7,325

6,334

6,088

6,008

6,636

7,639

5,712

7,202

6,919

7,761

8,673

8,283

9,396

9,206

9,334

8,201

7,764

6,360

5,970

5,364

Loss from operations

-8,042

-6,747

-6,682

-7,325

-6,334

-6,088

-6,008

-6,636

-7,639

-5,462

-6,952

-6,919

-7,761

-8,673

-8,283

-9,396

-9,206

-9,334

-8,201

-7,764

-6,360

-5,970

-5,364

Other income (expense):
Interest expense

-

-

-

-

-

-

10

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

33

57

81

105

127

149

175

199

220

243

268

282

279

149

57

-

Interest and investment income

167

148

214

257

226

173

177

43

32

32

45

44

39

59

50

80

53

-

-

-

-

-

-

Other (expense) income, net

-77

-11

-46

-63

70

-145

162

147

12

14

-5

28

-5

11

13

91

-22

-4

-2

4

9

2

1

Total other income, net

90

137

168

194

296

28

329

157

-13

-35

-65

-55

-115

-105

-136

-49

-212

-272

-284

-275

-140

-55

1

Net loss

-7,952

-6,610

-6,514

-7,131

-6,038

-6,060

-5,679

-6,479

-7,652

-5,497

-7,017

-6,974

-7,876

-8,778

-8,419

-9,445

-9,418

-9,606

-8,485

-8,039

-6,500

-6,025

-5,363

Net loss per share - basic and diluted (in dollars per share)

-0.50

-0.55

-0.56

-0.62

-0.62

0.54

-0.80

-1.98

-2.88

-11.58

-0.31

-0.32

-0.41

-0.46

-0.54

-0.61

-0.61

17.70

-0.55

-8.07

-13.14

-13.55

-13.42

Weighted-average common shares outstanding used in net loss per share - basic and diluted (in shares)

15,898

11,980

11,624

11,505

9,686

7,186

7,103

3,272

2,655

-54,780

22,563

21,796

19,093

18,698

15,512

15,373

15,335

15,378

15,297

996

494

444

399